GURUFOCUS.COM » STOCK LIST » USA » NYSE » Bristol-Myers Squibb Co (NYSE:BMY) » Definitions » Shiller PE Ratio
Switch to:

Bristol-Myers Squibb Co Shiller PE Ratio

: 49.97 (As of Today)
View and export this data going back to 1952. Start your Free Trial

As of today (2022-08-12), Bristol-Myers Squibb Co's current share price is $74.46. Bristol-Myers Squibb Co's E10 for the quarter that ended in Jun. 2022 was $1.49. Bristol-Myers Squibb Co's Shiller PE Ratio for today is 49.97.

The historical rank and industry rank for Bristol-Myers Squibb Co's Shiller PE Ratio or its related term are showing as below:

BMY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.82   Med: 26.13   Max: 53.63
Current: 50.07

During the past years, Bristol-Myers Squibb Co's highest Shiller PE Ratio was 53.63. The lowest was 14.82. And the median was 26.13.

BMY's Shiller PE Ratio is ranked worse than
78.02% of 496 companies
in the Drug Manufacturers industry
Industry Median: 24.56 vs BMY: 50.07

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Jun. 2022 was $0.660. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.49 for the trailing ten years ended in Jun. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Shiller PE Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.97 23.29 34.35 48.49 43.84

Bristol-Myers Squibb Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.84 43.67 43.84 50.52 51.78

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Bristol-Myers Squibb Co Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Shiller PE Ratio falls into.



Bristol-Myers Squibb Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bristol-Myers Squibb Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=74.46/1.49
=49.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's E10 for the quarter that ended in Jun. 2022 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Jun. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=0.66/123.3228*123.3228
=0.660

Current CPI (Jun. 2022) = 123.3228.

Bristol-Myers Squibb Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201209 -0.430 97.633 -0.543
201212 0.560 96.871 0.713
201303 0.370 98.209 0.465
201306 0.320 98.518 0.401
201309 0.420 98.790 0.524
201312 0.440 98.326 0.552
201403 0.560 99.695 0.693
201406 0.200 100.560 0.245
201409 0.430 100.428 0.528
201412 0.010 99.070 0.012
201503 0.710 99.621 0.879
201506 -0.080 100.684 -0.098
201509 0.420 100.392 0.516
201512 -0.080 99.792 -0.099
201603 0.710 100.470 0.871
201606 0.690 101.688 0.837
201609 0.720 101.861 0.872
201612 0.530 101.863 0.642
201703 0.940 102.862 1.127
201706 0.560 103.349 0.668
201709 0.510 104.136 0.604
201712 -1.410 104.011 -1.672
201803 0.910 105.290 1.066
201806 0.230 106.317 0.267
201809 1.160 106.507 1.343
201812 0.730 105.998 0.849
201903 1.040 107.251 1.196
201906 0.870 108.070 0.993
201909 0.830 108.329 0.945
201912 -0.550 108.420 -0.626
202003 -0.340 108.902 -0.385
202006 -0.040 108.767 -0.045
202009 0.820 109.815 0.921
202012 -4.450 109.897 -4.994
202103 0.890 111.754 0.982
202106 0.470 114.631 0.506
202109 0.690 115.734 0.735
202112 1.070 117.630 1.122
202203 0.590 121.301 0.600
202206 0.660 123.323 0.660

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (NYSE:BMY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bristol-Myers Squibb Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Bristol-Myers Squibb Co logo
Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Executives
Greenlees Sharon officer: SVP & Controller BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Shanahan Karin officer: EVP, Glob. Prod. Dev. & Supply BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Meyers Gregory Scott officer: EVP, Chief Digital & Tech Off. BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Weese Michelle officer: EVP, Corporate Affairs BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Hidalgo Medina Manuel director BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016
Rice Derica W director 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403
Price Paula A director ONE CVS DRIVE WOONSOCKET RI 02895
Mily Elizabeth officer: EVP, Strategy & BD BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540
Metcalfe Kathryn officer: EVP, Corporate Affairs BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Vessey Rupert officer: Pres., Research & Early Dev. C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Elkins David V officer: EVP, Chief Financial Officer C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Bonney Michael W director 65 HAYDEN AVE LEXINGTON MA 02421
Yale Phyllis R director
Ahmed Nadim officer: President, Hematology C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Haller Julia A director C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901

Bristol-Myers Squibb Co Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)